Eprosartan mesylate, an angiotensin II receptor antagonist
The title compound, eprosartan mesylate {systematic name: 2-butyl-1-(4-carboxybenzyl)-5-[(E)-2-carboxy-3-(thiophen-2-yl)prop-1-enyl]-1H-imidazol-3-ium methanesulfonate}, C23H25N2O4S+·CH3O3S−, one of the angiotensin II-receptor antagonists, is effective in regulating hypert...
Main Authors: | Jing-Jing Qian, Xiu-Rong Hu, Jianming Gu, Su-Xiang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union of Crystallography
2011-04-01
|
Series: | Acta Crystallographica Section E |
Online Access: | http://scripts.iucr.org/cgi-bin/paper?S1600536811006659 |
Similar Items
-
Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01) -
Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate
by: Abdul Ahad, et al.
Published: (2017-11-01) -
The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes
by: Botir T. Daminov, PhD, ScD, et al.
Published: (2013-06-01) -
Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
by: B. Sh. Karimova, et al.
Published: (2005-02-01) -
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)